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abstract
Objective: Analyzing the quality of sleep of hypertensive patients registered in the 
national registration system and monitoring of hypertensive patients. Methods: A 
cross-sectional study of quantitative and descriptive analyses with 280 hypertensive 
patients registered in the National Program of Hypertension and Diabetes of the Federal 
Government in the months from August to October 2011. Questionnaires were used 
which allowed for tracking sociodemographic data on hypertension and Pittsburgh Sleep 
Quality Index (PSQI). Results: The prevalence of poor sleep quality among respondents 
(156 hypertensive patients) and high rates of using medication for sleeping (106 
hypertensive patients) was observed. Other relevant data refers to the quality of sleep 
among hypertensive patients using sleep medication compared to those who do not use 
it (p≤0.01). Conclusion: Individuals with high blood pressure have a negative association 
with sleep quality.
descriPtOrs
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INTRODUCTION
Hypertension or High Blood Pressure (HBP) is con-
sidered a non-transmissible chronic disease, and one of the 
major challenges for public health around the world(1). It ac-
counts for about 13% of all global deaths(2). It affects approxi-
mately 25% of the world population, with a 60% increase of 
estimated cases by 2025(3). It is a common condition strongly 
associated with cardiovascular morbidity and mortality(4) 
with high social medical cost, affecting individuals in their 
productive stage of life(5). Population studies show the preva-
lence of hypertension in Brazil from 22.3% to 43.9%(4,6-7).
Another disease with high morbidity in the population 
is the Obstructive Sleep Apnea Syndrome (OSAS), and it is 
estimated that approximately 40% of hypertensive patients 
and 80% of those with resistant hypertension have OSAS(8-9) 
and about 55% individuals with OSAS have hypertension(10).
In hypertensive patients, the prevalence of OSAS is 
higher than that found among the general population, and 
there is evidence that diagnosis is associated with concomi-
tant hypertension. Thus, the need for combination treat-
ment, especially in patients with resistant hypertension 
should be considered(11).
Indicative factors that constitute pathophysiological 
mechanisms of hypertension(12) closely related to the de-
velopment of sleep disorders are: hyperactivity of the sym-
pathetic nervous system and the renin-angiotensin system 
(RAS); increase in the relative endotelina1/nitric oxide; the 
use of recombinant erythropoietin; the presence of second-
ary hyperparathyroidism; and especially, the increase in ex-
tracellular volume(13-14).
The quality of sleep and high blood pressure are strongly 
influenced by lifestyle, and individuals with hypertension 
are more likely to have sleep disorders(15).
The most common sleep disorders are restless legs syn-
drome, insufficient amount of hours slept, insomnia, and 
obstructive sleep apnea, the latter being the most common 
disorder in hypertensive individuals(16).
Therefore, understanding the quality of sleep in hyper-
tensive individuals is essential to assist in the care planning 
of this aspect in this population. Research that characterizes 
the profile of hypertensive patients in relation to the qual-
ity of sleep are scarce. Some studies have already attributed 
some sleep disorder as the main factor leading to the devel-
opment of hypertension. In this context, there is a gap in 
the literature that addresses hypertension as a causal factor 
of sleep disorders. This study aimed at evaluating quality of 
sleep of hypertensive individuals registered in the national 
registration system and monitoring of hypertensive patients.
METHOD
A cross-sectional, quantitative and descriptive study that 
included hypertensive individuals registered in the National 
Hypertension and Diabetes Program of the Federal Gov-
ernment in a southern city of Santa Catarina. In total, 782 
hypertensive patients were registered. A simple random 
sample was calculated with a sampling error of 5% and 
95% significance level, which resulted in 258 hypertensive 
individuals. A 10% surplus to was estimated compensate for 
losses, totaling 284 elderly.
Inclusion criteria were: being over 18 years old, diagnosed 
with hypertension, registered at the health district, and being 
available at least once in the three attempts of home visits. 
Exclusion criteria were: not being registered in the health 
district, not being available at the time of the home visit.
Data were collected at participant's homes through a 
structured interview with questions related to socioeco-
nomic data, clinical data and the Pittsburgh Index (PSQI), 
from August to October 2011.
To analyze socio-demographic profile, a questionnaire 
adapted from the Brazilian Institute of Geography and Sta-
tistics was designed.
Chart 1 shows the variables of interest of the study, 
composing the sociodemographic and clinical data of hy-
pertensive patients.
Chart 1 – Variables of interest of the study - Criciúma, SC, Brazil, 2011.
characteristics Variables
Socioeconomic data age, gender, marital status, ethnicity, family income, education level, height, weight, occupation, smoking and drinking habits.
Clinical data
Type and quantity of anti-hypertensive medication administered, time of hyperten-
sion diagnosis, systolic blood and diastolic blood pressure levels, type and amount 
of medications prescribed for sleeping.
Data such as weight and height registered into the 
program`s health handbook were relative to the month 
when the medication to control hypertension was suspend-
ed, as participants were monitored monthly by the program. 
Blood pressure measurements were performed by trained 
researchers, before the start of the interviews. Sphygmoma-
nometer (Premium) and Rappaport stethoscope (Premium) 
were used for the measurement of BP.
In order to investigate subjective sleep quality, we used 
the Pittsburgh Index (PSQI). The main purpose of this in-
strument is evaluating the subjective quality and the occur-
rence of sleep disorders. The questionnaire consists of ten 
questions that form seven components: 1) Subjective sleep 
quality; 2) Sleep latency; 3) Sleep duration; 4) Habitual 
sleep efficiency; 5) Sleep disturbances; 6) Use of sleep medi-
cations; 7) Daytime disturbances. Each component can vary 
in a scale of 0 to 3, where 0 indicates very good quality and 
3 is very bad quality. The maximum score of the instrument 
is 21 points; a score >5 indicates that the patient is having 
great difficulties in at least two components or moderate 
difficulty in more than three components, thus, the higher 
the score, the worse the quality of sleep of the individual.
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Data were tabulated in Microsoft Excel and analyzed 
using the SPSS 18.0 statistical program for Windows. 
The Mann-Whitney U test and chi-square Pearson with 
p ≤ 0.05 were used. We also calculated the Odds Ratio as 
a measure of association, with a 95% confidence interval. 
The research project was approved by the Research Ethics 
Committee of Universidade do Extremo Sul Catarinense 
- UNESC number 194/2011. The ethical principles of vol-
untary and informed participation were observed for each 
subject, who spontaneously signed the Informed Consent 
Form, authorizing the application of instruments for data 
collection as recommended in Resolution No. 196/1996 of 
the National Health Council, effective on the date the study 
was approved by the Research Ethics Committee.
RESULTS
The descriptive analysis of the 280 hypertensive respon-
dents allowed us to obtain the results presented below, map-
ping the sociodemographic profile of the study population 
(Table 1), data on hypertension of respondents (Table 2), 
medication for sleeping correlated with components of the 
PSQI instrument (Figure 1), and medication for sleeping 
correlated to total PSQI scores (Table 3).
The average age of the participants was 63.0 (± 11 years), 
the majority were females, of white ethnicity, with incom-
plete primary education, living with a regular companion, 
retired, with family income of 1-3 minimum wages, which 
at the time of data collection was R$545.00.
Average diagnosis time of respondents was 12.0 years 
(± 9.4 years). More than half of the respondents had un-
dergone antihypertensive treatment for more than six years, 
and the prevalent type of treatment was the association 
of medication and non-medication. For antihypertensive 
treatment, respondents used more than three medications 
with daily dosage varying from two to three doses in most 
cases. Physical activity was barely present among respon-
dents, 16.5% reported practicing it regularly, and 12.2% 
did not practice it regularly. Smoking and drinking habits 
were present among hypertensive respondents, 11.8% and 
12.9%, respectively. When asked about their opinion on the 
amount of salt in their diets, almost half revealed consider-
ing it little and/or poor (Table 2).
Table 1 – Subjects distribution according to sociodemographic 
variables - Criciúma, SC, Brazil, 2011.
Variables   n(%) n=280 
average age 63.0(±11.0)IC (95%): 61.70 - 64.29
Median 64.0
gender
Male 91(32.5)
Female 189(67.5)
Family income
<1 minimum wage 14(5.0)
1 to 3 minimum wages 224(80.0)
4 to 6 minimum wages 33(11.8)
>6 minimum wages 7(2.5)
education level
Illiterate 20(7.1)
Literate (can read and write their name) 16(5.7)
Incomplete Primary Education 185(66.1)
Completed Primary Education 28(66.1)
Incomplete Secondary Education 5(1.8)
Complete Secondary Education 3(2.0)
Incomplete Superior Education 2(0.7)
Post-Graduate 1(0.4)
Marital status
Living with a companion 203(72.5)
Living with an irregular companion 2(0.7)
Does not live with a companion 2(0.7)
Does not have a companion 43(15.4)
Living alone 30(10.7)
continued... continued...
...continuation
Table 2 – Data on hypertensive respondents - Criciúma, SC, Bra-
zil, 2011.
Variables n(%) n=280
diagnosis time (Standard Deviation) 12.0(±9.4)IC (95%): 10.89 – 13.10
treatment time
<1 year 9(3.2)
1 to 2 years 18(6.4)
3 to 5 years 56(20.0)
6 years 22(7.9)
>6 years 175(62.5)
treatment type
Exclusively with medication 140(50.0)
Exclusively non-medication 2(0.7)
Medication + non-medication 138(49.3)
Variables   n(%) n=280 
Occupation
Retired 128(45.7)
Pensioner 33(11.8)
Works at home/housewife 72(25.7)
Unemployed 2(0.7)
Other 45(16.1)
religion
Catholic 224(80.0)
Evangelican 51(18.2)
None 2(0.7)
Others 3(1.1)
ethnicity
White 246(87.9)
Mixed 6(2.1)
Black 28(10.0)
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...continuation
Variables n(%) n=280
amount of medication/day
One Drug 28(10.0)
Two Drugs 64(22.9)
Three Drugs 55(19.6)
>4 Drugs 133(47.5)
dosage/day
One Dose 31(11.1)
Two Doses 124(44.3)
Three Doses 110(39.3)
>4 Doses 15(5.4)
Use of everyday Medication
Yes 215(76.8)
No 65(23.2)
Practice of exercise (3 or more times a 
week)
Regularly 46(16.5)
Irregularly 34(12.2)
None 200(71.3)
smoking Habits
Yes 26(9.3)
No 190(67.8)
Sometimes 7(2.5)
Quit 57(20.4)
alcohol consumption
Yes. every day 3(1.1)
Yes. on weekends 33(11.8)
No 243(86.8)
Quit/Has stopped drinking 1(0.4)
amount of salt in diet
Normal 112(40.1)
Little/Poor 139(49.8)
Salty 28(10.0)
Figure 1 shows the analysis of the sleeping medication 
compared to total score of each PSQI instrument com-
ponents, which vary on a scale of 0 to 3 points and total 
score of the instrument vary on a scale ranging from 0 to 21 
points. Data stratification of each component was conduct-
ed comparing individuals who used medication for sleeping 
and those who did not use them. We identified that 106 hy-
pertensive patients used medication for sleeping, while 174 
reported not using them. When comparing the averages of 
the components among individuals who used medication 
and those who did not, we found a statistical difference of 
p≤0.05 when compared to component 1: Subjective sleep 
quality. When compared to components 2: Sleep latency, 
4: Habitual sleep efficiency, 5: Sleep disturbances, 6: Use 
of sleep medication and 7: Daytime disturbances, we ob-
served a statistical difference of p≤0.01. Component 3: 
Sleep duration showed no statistical difference. In the 
overall score, a statistically significant difference p≤0.01 
was observed when comparing the overall quality of sleep 
of hypertensive patients that use sleeping medication with 
those who do not.
C1 C2 C3 C4 C5 C6 C7 Total
Using Medication Not Using Medication
6,0
4,0
2,0
0,0
8,0
10,0
12,0
14,0
* # #
#
#
#
#
Figure 1 – Comparison of scores of each component of the PSQI 
instrument x Use of medication for sleeping - Criciúma, SC, Brazil.
Legend: C1 - Component 1 (Subjective sleep quality), C2 - Com-
ponent 2 (Sleep Latency), C3 - Component 3 (Sleep Duration), 
C4 - Component 4 (Habitual sleep efficiency), C5 - Component 
5 (Sleep disturbances), C6 - Component 6 (Use of sleep medica-
tions), C7 - Component 7 (Daytime disturbances). Total refers to 
the total score of the instrument, on a scale ranging from 0 to 
21 points. Statistical method employed: Mann-Whitney U test. 
(#: p≤0.01; *: p ≤ 0.05).
Table 3 shows the relationship established between the 
use of medication to sleep and sleep quality. The global 
PSQI score showed that 156 hypertensive patients had 
bad sleep quality and 124 had good sleep quality. Of the 
156 hypertensive who reported poor sleep quality, 97 were 
using medication to sleep and of the 124 who reported 
good quality sleep, only nine were using medication to 
sleep. In this analysis, when comparing sleep quality with 
the use of sleeping medication, the data revealed a statistical dif-
ference (p≤0.01). The probability Odds Ratio 21 (95% CI, 9.9-
44.54) was calculated, revealing that hypertensive patients who 
did not use sleeping medication were 21 times more likely to 
have good sleep quality in comparison to hypertensive patients 
using sleep medication, a statistically significant difference.
Table 3 – Relationship between medication and sleep quality - 
Criciúma, SC, Brazil, 2011.
relationship between 
Medication and sleep Quality
Quality of sleep
total
good bad
Use of Medication
does not use it 115 59 174
Uses it 9 97 106
total 124 156 280
Statistical method employed: Pearson Chi-square test (p≤0.001).
DISCUSSION
In 2010, hypertension was responsible for the highest 
percentage of attributable death (13%), and the leading 
cause of disability, accounting for over 20% of the world 
rate for life years adjusted for disability in adults of 70 years 
of age or more, and about 15% of those between 50 and 69 
years(17). The evidence that OSAS is a key risk factor in the 
development of hypertension and consequent development 
of cardiovascular diseases is clear(18-19).
In all regions in Brazil, the prevalence of self-reported 
hypertension was higher among women, which may be 
partly justified by the greater use of health services by wom-
en, which provides them with the opportunity to receive a 
medical diagnosis of hypertension(20).
It was found that hypertensive individuals are more 
likely to develop emotional disorders such as anxiety and 
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depression, triggering changes in sleep, being strongly re-
lated to the hypertension risk factor for sleep disorders(21).
Studies have indicated that the presence of untreated 
sleep disorders, insomnia and especially OSAS are associ-
ated with an increased risk of fatal and non-fatal cardiovas-
cular disease(22), showing a high prevalence of OSAS in hy-
pertensive individuals, and on the other hand, hypertension 
is found in a large proportion of individuals with OSAS(23).
Adults with hypertension had reduced cerebral circu-
lation in areas that are normally always active, and there 
is compensation with the increased blood flow to isolated 
areas of the brain. With time, these cerebrovascular changes 
could manifest with cognitive or behavioral changes includ-
ing sleep disturbance, making it difficult to concentrate and 
resulting in fatigue(24).
A study evaluated the occurrence of OSAS in 394 
hypertensive Swedish patients, revealing the occurrence 
of OSAS in 59% of the studied population, but elevated 
blood pressure was not observed in this study(11).
The worldwide prevalence of hypertension complaints 
and sleep disorders has increased in recent decades, and 
growing evidence suggests that the conditions of poor 
sleep is associated with increased prevalence and inci-
dence of hypertension(25-26).
It should be noted that before establishing antihyper-
tensive treatment, investigations about the quality of sleep 
need to be conducted because drug therapy can influence 
the onset of sleep disorders in these individuals who are al-
ready more prone to them. Often the treatment of sleep dis-
orders contributes to better control of blood pressure levels.
Even though the literature describes the fact that hyper-
tensive individuals are likely to have problems related to sleep, 
there is a lack of attention from the public health in relation 
to this issue because our findings are from populations that 
are serviced by the public health service. Thus, it is expected 
that these individuals receive attention often contributing to 
improved overall health, resulting in the reduction of public 
spending on maintaining the health of this population.
CONCLUSION
Considering the results of this study, it was found that 
hypertensive individuals have poorer quality sleep than 
those with normotensive individuals, and those who use 
sleeping medication had poorer quality of sleep compared 
to hypertensive patients who did not use medication.
The incidence of respondents who used medications for 
sleeping was high, suggesting a true analysis of how sleep 
quality of these individuals was being affected, possibly sig-
nificantly interfering on their quality of life.
Although our findings show that hypertensive individuals 
have poor sleep quality, data should be treated with caution 
because sleep quality was not investigated prior to the diag-
nosis of hypertension, nor was the sleep quality of normoten-
sive individuals of the same health region so results could be 
compared. It is recommended that further studies continue to 
clarify these aspects due to the relevance of this topic.
resUMO
Objetivo: Analisar a qualidade do sono de hipertensos registrados no sistema nacional de cadastramento e acompanhamento de 
hipertensos. Método: Estudo transversal, quantitativo e descritivo realizado com 280 usuários hipertensos cadastrados no Programa 
Nacional de Hipertensão e Diabetes do Governo Federal nos meses de agosto a outubro de 2011. Foram aplicados questionários que 
permitiram traçar o perfil sociodemográfico, dados sobre hipertensão arterial sistêmica e Índice de Qualidade de Sono de Pittsburgh. 
Resultados: Verificou-se predomínio da qualidade de sono ruim entre os entrevistados (156 hipertensos) e altas taxas de uso de 
medicações para dormir (106 hipertensos). Outro dado relevante refere-se à qualidade de sono entre hipertensos que utilizam medicação 
para dormir comparados àqueles que não utilizam (p≤0,01). Conclusão: Indivíduos com hipertensão arterial sistêmica apresentam 
associação negativa com a qualidade do sono.
descritOres
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resUMen
Objetivo: Analizar la calidad del sueño de hipertensos registrados en el sistema nacional de registro y seguimiento de hipertensos. 
Método: Estudio transversal, cuantitativo y descriptivo, llevado a cabo con 280 usuarios hipertensos registrados en el Programa 
Nacional de Hipertensión y Diabetes del Gobierno Federal en los meses de agosto a octubre de 2011. Fueron aplicados cuestionarios 
que permitieron trazar el perfil sociodemográfico, datos acerca de la hipertensión arterial sistémica e Índice de Calidad de Sueño de 
Pittsburgh. Resultados: Se verificó el predominio de la mala calidad de sueño entre os entrevistados (156 hipertensos) y altas tasas 
de uso de fármacos para dormir (106 hipertensos). Otro dato relevante se refiere a la calidad de sueño entre hipertensos que utilizan 
fármacos para dormir comparados a los que no utilizan (p≤0,01). Conclusión: Individuos con hipertensión arterial sistémica presentan 
asociación negativa con la calidad del sueño.
descriPtOres
Hipertensión; Sueño; Síndromes de la Apnea del Sueño; Salud Pública; Evaluación en Salud.
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